Showing results (1-10 of 128) with videos related to
Sort By:
Pageof 13
Endocrine|June 5, 2003
Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both?Rachel Saunders-PullmanCurrent Neurology and Neuroscience Reports|July 2, 2013
The association between ß-glucocerebrosidase mutations and parkinsonismMatthew Swan, Rachel Saunders-PullmanMuscle & Nerve|December 12, 2013
Atypical presentation of late-onset Tay-Sachs diseaseAndres Deik, Rachel Saunders-PullmanCurrent Drug Abuse Reviews|May 7, 2010
Substance abuse and movement disordersMarta San Luciano, Rachel Saunders-PullmanMovement Disorders : Official Journal of the Movement Disorder Society|July 30, 2013
Primary dystonia: moribund or viableSusan B Bressman, Rachel Saunders-PullmanAddiction Biology|June 28, 2006
Movement disorders and alcohol misuseChristopher W Hess, Rachel Saunders-PullmanArchives of Pathology & Laboratory Medicine|December 1, 2012
Causes of death of patients with lung cancerLarry Nichols, Rachel Saunders, Friedrich D KnollmannHealthcare Technology Letters|October 5, 2023
A comparison of conductive ink usage optimization techniques used in fabrication of epidermal UHF radio frequency identification tags for medical and sensing applicationsDumtoochukwu Obiora Oyeka, John Batchelor, Rachel SaundersCurrent Drug Abuse Reviews|October 4, 2012
Substance of abuse and movement disorders: complex interactions and comorbiditiesAndres Deik, Rachel Saunders-Pullman, Marta San LucianoNeurology|August 15, 2022
Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk CohortsKellyann Niotis, Andrew B West, Rachel Saunders-PullmanPageof 13